Literature DB >> 1467571

Biology and therapy of glial tumors.

J Weingart1, H Brem.   

Abstract

Glial tumors remain challenging problems for the clinician and researcher. Despite more aggressive therapy, the majority of these tumors recur locally. This review will provide an update on the new strategies being developed to treat gliomas. Advances in our understanding of the biology of glial tumors will provide new targets at which to direct therapy.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1467571

Source DB:  PubMed          Journal:  Curr Opin Neurol Neurosurg        ISSN： 0951-7383


  3 in total

1.  Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes.

Authors:  S Tanaka; H Kamitani; M R Amin; T Watanabe; H Oka; K Fujii; T Nagashima; T Hori
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

2.  Redifferentiation therapy in brain tumors: long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term 1-alpha-hydroxycholecalciferol.

Authors:  P Trouillas; J Honnorat; P Bret; A Jouvet; J P Gerard
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

3.  Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.

Authors:  Matthew J McGirt; Khoi D Than; Jon D Weingart; Kaisorn L Chaichana; Frank J Attenello; Alessandro Olivi; John Laterra; Lawrence R Kleinberg; Stuart A Grossman; Henry Brem; Alfredo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2009-03       Impact factor: 5.115
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.